Directory
>
Kyle Dow
Kyle Dow
Vice President Corporate Development | Skyhawk Therapeutics
Boston, Massachusetts, United States
Kyle Dow
Summary
Kyle Dow is a seasoned professional in corporate development with a strong background in biomedical engineering and biotechnology. Currently serving as the Vice President of Corporate Development at Skyhawk Therapeutics, he has a proven track record in business strategy, competitive analysis, and cross-functional team leadership. His diverse experience spans various roles in business development, including positions at Entasis Therapeutics and Innoviva Specialty Therapeutics. With an MBA from the Wharton School, Kyle combines technical expertise with strategic insight to drive growth in the life sciences sector. His leadership experience in startups and established companies positions him as a key player in the industry. Kyle is passionate about innovation and the development of medical devices that enhance patient outcomes. He is known for his analytical approach and ability to navigate complex business challenges.
Kyle Dow
Work Experience
Vice President Corporate Development at
Skyhawk Therapeutics
March 2024 - Present
Vice President of Business Development at
Innoviva Specialty Therapeutics, Inc.
July 2022 - March 2024
Vice President Of Business Development at
Entasis Therapeutics
January 2022 - July 2022
Senior Director Business Development at
Entasis Therapeutics
January 2019 - January 2022
Director, Business Development at
Entasis Therapeutics
January 2017 - January 2019
Associate Director, Business Development & Commercial Planning at
Entasis Therapeutics
January 2015 - January 2017
Engagement Manager at
Health Advances
January 2013 - January 2015
Consultant at
Jefferson Distributing
January 2011 - January 2012
Product Engineer II at
Siemens Healthineers
January 2007 - January 2010
Kyle Dow
Education
Wharton School, Master Of Business Administration (M.B.A.)
January 2010 - January 2012
Rensselaer Polytechnic Institute, Bachelor’s Degree
Frequently Asked Questions about Kyle Dow
What company does Kyle Dow work for?
Kyle Dow is a Vice President Corporate Development at Skyhawk Therapeutics, a company specializing in Commercial physical research.
Where Kyle Dow graduated from?
Kyle Dow holds a degree in from Wharton School.
Who is Kyle Dow?
Kyle Dow is a seasoned professional in corporate development with a strong background in biomedical engineering and biotechnology. Currently serving as the Vice President of Corporate Development at Skyhawk Therapeutics, he has a proven track record in business strategy, competitive analysis, and cross-functional team leadership. His diverse experience spans various roles in business development, including positions at Entasis Therapeutics and Innoviva Specialty Therapeutics. With an MBA from the Wharton School, Kyle combines technical expertise with strategic insight to drive growth in the life sciences sector. His leadership experience in startups and established companies positions him as a key player in the industry. Kyle is passionate about innovation and the development of medical devices that enhance patient outcomes. He is known for his analytical approach and ability to navigate complex business challenges.
Kyle`s contact details
Colleagues
Chief Scientific Officer
Vice-President, Chemistry, Skyhawk Therapeutics
Executive Director, Translational Biomarkers
Executive Director, Bioinformatics
Chief Medical Officer
Senior Vice President Chemistry
Senior Vice President Legal
Executive Director Discovery Biology